Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2001-03-30
2003-11-18
Eyler, Yvonne (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S325000, C435S320100
Reexamination Certificate
active
06649346
ABSTRACT:
BACKGROUND OF THE INVENTION
Alzheimer's disease is a degenerative brain disorder that is characterized clinically by progressive loss of memory and cognitive impairment. Pathologically, the disease is characterized by lesions comprising neurofibrillary tangles, cerebrovascular amyloid deposits, and neuritic plaques. The cerebrovascular amyloid deposits and neuritic plaques contain amyloid-&bgr; peptide. The aggregation of amyloid-&bgr; peptide is instrumental in the pathogenesis of Alzheimer's disease.
Amyloid-&bgr; peptide is derived from amyloid-&bgr; precursor protein (APP). APP is a cell-surface protein with a large N-terminal extracellular sequence, a single transmembrane region (TMR) and a short C-terminal cytoplasmic tail. APP is processed by proteolysis in all cells. Initially, &agr;- and &bgr;-secretases cleave APP at defined extracellular sequences just outside of the TMR to release a large N-terminal extracellular fragment. Thereafter, &ggr;-secretase cuts APP in the middle of the TMR to generate small extracellular peptides and a C-terminal fragment comprising half of the TMR and the full cytoplasmic tail. See, e.g., Selkoe (1998) Trends Cell Biol. 8, 447-453; Bayer et al. (1999) Mol. Psychiatry 4, 524; Haass et al. (1999) Science 286, 916-919; Price et al. (1998) Ann. Rev. Gevet 32, 461-493.
Cleavage of APP by &bgr;- and &ggr;-secretase produces the amyloid-&bgr; peptides (AP40 and AP42) implicated in the pathogeneses of Alzheimer's disease. Various methods for the diagnosis and monitoring of the disease involve assessing the cleavage of APP and detection of amyloid-&bgr; peptide. However, these methods suffer from various disadvantages including the insolubility of amyloid-&bgr; peptide, cross-reactivity of antibodies against the peptide with the precursor APP, and different levels of protease activity in different body fluids.
The &ggr;-cleavage of APP is mediated by presenilins, intrinsic membrane proteins that may correspond to &ggr;-secretase and that are mutated in some cases of familial Alzheimer's disease. See, e.g., Esler et al. (2000) Nat. Cel. Biol. 2, 428-434. Also, &ggr;-cleavage occurs in APP-homologs that are not implicated in Alzheimer's disease. For example, Notch proteins are membrane proteins that are also cleaved in the middle of the TMR in a presenilin-dependent reaction. See, e.g. Ye et al. (1999) Nature 398, 525-529; De Strooper et al. (1999) Nature 398, 518-522; Struhl et al. (1999) Nature 398, 522-525. Notch proteins are cell-surface proteins involved in intercellular signaling in which presenilin-dependent cleavage liberates a cytoplasmic fragment that functions in nuclear transcription. Struhl et al. (2000) Mol. Cell 6, 625-636. Sterol regulatory element binding proteins (SREPPs) are also cleaved in the TMRs to generate nuclear transcription factors. Brown et al. (2000) Cell 100, 391-398. In contrast, the physiological significance of &ggr;-cleavage of APP, and in particular the biological role of the cytoplasmic tail fragment, has heretofore been unclear. In accordance with the present invention it has been discovered that the cytoplasmic tail forms a functional complex with nuclear proteins, and that the complex is a potent stimulator of transcription. The present invention thus provides new methods for identifying agents that affect the cleavage of APP.
SUMMARY OF THE INVENTION
The present invention provides a method of identifying an agent that affects the cleavage of APP comprising contacting a cell containing APP modified in the C-terminal cytoplasmic tail to allow detection of nuclear localization with a candidate agent and measuring nuclear localization of a C-terminal cytoplasmic cleavage product of APP in the presence and absence of the agent.
In another embodiment, the present invention provides a method of identifying an agent that affects the cleavage of APP comprising providing a cell containing APP and a protein that interacts with the C-terminal cytoplasmic cleavage product of APP to regulate transcription, wherein the protein is modified to allow detection of nuclear localization of the C-terminal cytoplasmic cleavage product of APP; contacting the cell with a candidate agent; and measuring nuclear localization of the C-terminal cytoplasmic cleavage product of APP in the presence and absence of the agent.
The invention further provides agents identified by the foregoing method, and compositions comprising the agents.
In another embodiment, the invention is directed to vectors, transfected cells and kits useful for identifying an agent that affects the cleavage of APP.
REFERENCES:
patent: 5928882 (1999-07-01), Sabo et al.
patent: 5972634 (1999-10-01), Tanzi et al.
patent: 5981208 (1999-11-01), Tamburini et al.
patent: 6020143 (2000-02-01), St. George-Hyslop et al.
patent: 6043224 (2000-03-01), Lee et al.
patent: 6083904 (2000-07-01), Artavanis-Tsakonas
patent: 6114133 (2000-09-01), Seubert et al.
patent: 034884 (2001-10-01), Peraus
patent: 061553 (2002-05-01), Maury et al.
patent: WO 00/34511 (2000-06-01), None
patent: 9904746 (1999-02-01), None
patent: 0002897 (2000-01-01), None
Duilio et al., 1991, Nucleic Acids Research, vol. 19, No. 19, pp. 5269-5274.*
Kidd et al., “Ligand-induced cleavage and regulation of nuclear entry of Notch inDrosophila melanogasterembryos”, Genes & Development 12:3728-3740, 1998.
Steiner et al., “A Loss of Function Mutuation of Presenilin-2 Interferes with Amyloid &bgr;-Peptide Production and Notch Signaling”, Journal of Biological Chemistry, 274:28669-28673, 1999.
Octave et al., “The Role of Presenilin-1 in the &ggr;-Secretase Cleavage of the Amyloid Precursor Protein of Alzheimer's Disease”, Journal of Biological Chemistry, 275:1525-1528, 2000.
Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell. Jul. 12, 2002;110(1):55-67.
Kinoshita A, Whelan CM, Berezovska O, Hyman BT. The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem. Aug. 9, 2002;277(32):28530-28536.
Bruni P, Minopoli G, Zambrano N, Hansen U, Russo T. A possible function of the APP-Fe65 Complex in gene regulation. Abst Soc Neurosci 2001;27:2084.
Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science Jul. 6, 2001;293(5527):115-120.
Cupers P, Orlans I, Craessaerts K, Annaert W, De Strooper B. The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distrubutes partially in a nuclear fraction of neurones in culture. J Neurochem Sep. 2001;78(5):1168-1178.
Gao Y. Pimplikar SW. The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci USA Dec. 18, 2001;98(26):14979-14984.
Kimberly WT, Zheng JB, Guenette SY, Selkoe DJ. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem Oct. 26, 2001;276(43):40288-40292.
Kimberly WT, Zheng JG, Guenette SY, Selkoe DJ. The amyloid precursor protein P6 C-terminal fragment localizes to the nucleus in COS cells. Abst Soc Neurosci 2001;27:25.
Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron MM, Teplow DB, Haass C. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep Sep. 2001;2(9):835-841.
Sudol M, Silwa K, Russo T. Functions of WW domains in the nucleus. FEBS Lett 2001;490:190-195.
Wolfe MS, Haass C. The role of presenilins in gamma-secretase activity. J Biol Chem Feb. 23, 2001;276(8):5413-5416.
Yu C, Kim SH, Ikeuchi T, Xu H, Gasparini L, Wang R, Sisodia SS. Characterization of a presenilin-mediated amyloid precursor protein carboxy-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma -secretase processing
Cao Xinwei
Südhof Thomas C.
Baker & Botts L.L.P.
Board of Regents The University of Texas
Chernyshev Olga N.
Eyler Yvonne
LandOfFree
Methods of identifying agents that affect cleavage of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying agents that affect cleavage of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying agents that affect cleavage of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3173487